We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

In Vitro Systems and Inhalation Toxicology
In Vitro Systems and Inhalation Toxicology
Blog

In early July, experts from around the world met in Nice, France, to share and discuss the latest innovations and research in the context of human lung in vitro models. This blog highlights some of the topics covered during the event.

Read More

Going with the Flow
Going with the Flow
Blog

This month we sat down with Dr Omar Jina, Chief Commercial Officer at Syrris Ltd., to discuss flow chemistry, its applications and the push to raise awareness of this transformative technology.

Read More

Treating Diseases Associated with Pathogenic Proteins Expressed by Human Endogenous Retroviruses
Treating Diseases Associated with Pathogenic Proteins Expressed by Human Endogenous Retroviruses
Blog

We recently spoke to Dr. Hervé Perron, HDR, Chief Scientific Officer at GeNeuro to learn about their progress developing new treatments for neurological and autoimmune diseases associated with pathogenic proteins expressed by human endogenous retroviruses (HERVs).

Read More

A Move Towards Precise Management of Bacterial Infections
A Move Towards Precise Management of Bacterial Infections
Blog

Following the recent FDA approval of a procalcitonin assay, we spoke with a representative from Fujirebio Diagnostics, Inc. to learn how measuring this important biomarker will improve the healthcare landscape.

Read More

The Sequencing Technology Behind The World's Fastest Genetic Diagnosis
The Sequencing Technology Behind The World's Fastest Genetic Diagnosis
Blog

In February 2018, a team at Rady Children's Institute for Genomic Medicine broke the world record for the fastest genetic diagnosis when they delivered a rare disease diagnosis in just 19 hours 30 minutes. We caught up with John Reynders, CEO of Alexion, to discuss how the record was broken, and why diagnosing rare diseases is important in modern medicine.

Read More

The Digital Solutions Accelerating Scientific Discovery
The Digital Solutions Accelerating Scientific Discovery
Blog

Science advances at a rapid pace, and supporting technologies and infrastructures have to adapt accordingly. One of the latest evolutions in technology is the shift from traditional software and hardware tools to newer cloud-based services. In this blog, Thermo Fisher Scientific's Karen Velardi looks at, we look at the different cloud services that are changing the way modern research is done.

Read More

More Tools and More Time: An Easier Future for Bioinformaticians?
More Tools and More Time: An Easier Future for Bioinformaticians?
Blog

In the second of a two-part blog series, we talk with Genestack CEO Misha Kapushesky on the developments in Bioinformatics that he’s most excited about, and the latest modular additions to Genestack's bioinformatics platform.

Read More

Supporting the Development of Regenerative Medicines
Supporting the Development of Regenerative Medicines
Blog

Regenerative medicine is a branch of translational research which focuses on methods to regrow, repair or replace human cells, tissues or organs. We recently spoke with Michael May, President & CEO of CCRM, an organization supporting the development of regenerative medicines and associated technologies to learn more about their latest projects and collaborations.

Read More

Developing Bispecific Antibodies
Developing Bispecific Antibodies
Blog

Bispecific antibodies (bsAbs) harness the specificities of two antibodies and combine them to simultaneously recognize different antigens or epitopes. This ‘two-target’ functionality has meant that interest in their use for therapeutic applications has increased considerably. We spoke to GenScript’s Liusong Yin, PhD, and Jie Ma, to learn more about bispecific antibodies and the associated challenges developing them.

Read More

Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer
Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer
Blog

During this year’s AACR Annual Meeting we spoke to Dr. Delphine Lissa and Dr. Ana Robles from the National Cancer Institute to learn more about the team’s most recent study on the use of two specific biomarkers for risk stratification of stage I lung cancer patients.

Read More